Recruiting

ICG

Sponsor:

Shanglei Liu

Code:

NCT06254833

Conditions

Perfusion; Complications

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Accepted

Interventions

micro dosing of ICG

Study Details

Brief summary:

using microdosing of ICG vs regular dosing of ICG for perfusion assessment during surgery

Conditions

Perfusion; Complications

Study ID

NCT06254833

Start date

Nov 1, 2023

Status verified date

Feb, 2024

Completion date

Nov 1, 2024

Anticipated

Primary completion date

Oct 1, 2024

Anticipated

Eligibility Criteria

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Accepted

Inclusion Criteria:

  • all patient undergoing intestinal resection surgery

Exclusion Criteria:

  • pregnancy, renal insufficiency

Study Design

Enrollment

20 participants

Anticipated

Allocation

Randomized

Intervention Model

Single group

Primary purpose

Diagnostic

Interventions and Outcome Measures

Arms

no intervention: regular dose ICG

active comparator: micro dose icg

Interventions

micro dosing of ICG

smaller dose of injection of ICG. All devices used are FDA approved in clinical use.

Primary outcome measure

  • ability to assess perfusion [ Time Frame: up to 30 days post operatively ]

Central Contacts and Locations

Central contacts

Shanglei Liu

(858)249-1837jtt005@health.ucsd.edu

Locations

UC San Diego

Recruiting

La Jolla, California, United States, 92093

More Information

Sponsor

Shanglei Liu

Last update posted

Feb 12, 2024

Last verified

Feb, 2024

Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-10. This information was provided to ClinicalTrials.gov by Shanglei Liu on 2024-02-12.